Chinese infant formula maker Synutra International has hit back at “irresponsible” reports that allege a link between hormone levels in its milk powder to premature development and sexual precocity.

The company yesterday (9 August) released a statement in response to the media reports in China that linked the group’s formula to premature breast development in girls.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Liang Zhang, chairman and CEO of Synutra, said that “certain parties” in the media had attempted to “create a crisis” and that the reports were “based on speculation instead of scientific evidence”.

“Certain members of the media promulgated these claims despite the fact that many different external factors have been linked to premature development in children, and, additionally, China’s CDC and several leading scientists already stated publicly that there was no evidence linking our products to such symptoms,” Zhang said.

“We are completely confident that our products are safe and our quality levels are industry-leading. We do not add hormones to our products and we have invested heavily in research, quality control, formulations and ingredients. We have participated in exhaustive quality testing at all required government levels, including with the relevant state agencies and industry groups. Additionally, our upstream ingredient suppliers are also reliable and trusted around the world,” he added.

See Also:

Synutra said it is currently in the process of taking legal action to protect its brand, and will “prosecute the parties responsible for these accusations to the furthest extent possible”.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company’s shares, which are listed on the Nasdaq, plunged in the wake of the reports.